Safety and efficacy of icatibant self-administration for acute hereditary angioedema

We evaluated the efficacy and safety of icatibant self-administration in 15 patients with hereditary angioedema (HAE) types I or III, for 55 acute attacks (mostly severe or very severe). Icatibant self-administration was generally effective: first symptom improvement occurred in 5 min–2 h (HAE type...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Boccon-Gibod, I, Bouillet, L
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2012
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3390482/
https://ncbi.nlm.nih.gov/pubmed/22519593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2249.2012.04574.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk